Skip to content

Clinical trials

Lung Neoplasms trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Lithuania Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20151
20181
20192
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lithuanian University of Health Sciences3
Gustave Roussy, Cancer Campus, Grand Paris2
Daiichi Sankyo1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Nutricia Research1
Oslo University Hospital1
Vestre Viken Hospital Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms11
Carcinoma, Non-Small-Cell Lung3
Neoplasms2
Adenocarcinoma1
Adenocarcinoma of Lung1
Cachexia1
Colorectal Neoplasms1
Emaciation1
Pancreatic Neoplasms1
Wasting Syndrome1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.